标题
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
作者
关键词
-
出版物
Frontiers in Psychiatry
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-04-28
DOI
10.3389/fpsyt.2020.00315
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior
- (2019) Chen-Jie Shen et al. NATURE MEDICINE
- Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
- (2019) Thércia G. Viana et al. NEUROPHARMACOLOGY
- Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats
- (2019) Alice Hartmann et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder
- (2019) Douglas T. Leffa et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment
- (2019) Mohaddeseh Ebrahimi-Ghiri et al. BEHAVIOURAL BRAIN RESEARCH
- Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
- (2019) Fatemeh Khakpai et al. BIOMEDICINE & PHARMACOTHERAPY
- Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
- (2019) Jacob D. Meyer et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression
- (2019) C. Kirkedal et al. NEUROCHEMISTRY INTERNATIONAL
- Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
- (2019) Pablo Romero-Sanchiz et al. NEUROPHARMACOLOGY
- Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression
- (2019) Xenia Gonda et al. Frontiers in Cellular Neuroscience
- Bipolar disorder and the endocannabinoid system
- (2019) Shokouh Arjmand et al. ACTA NEUROPSYCHIATRICA
- Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: Current approaches for therapeutics development
- (2019) Thuy Nguyen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
- (2019) Carolina Muguruza et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
- (2019) Luara A. Batista et al. NEUROSCIENCE LETTERS
- Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling
- (2019) Shan-shan Xue et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
- (2019) Faith Borgan et al. JAMA Psychiatry
- NMDAR Hypofunction Animal Models of Schizophrenia
- (2019) Gloria Lee et al. Frontiers in Molecular Neuroscience
- Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis
- (2019) Martina Rojnic Kuzman et al. EUROPEAN PSYCHIATRY
- Impaired brain endocannabinoid tone in the activity‐based model of anorexia nervosa
- (2019) Roberto Collu et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
- (2019) Valéria Almeida et al. NEUROPHARMACOLOGY
- Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits
- (2019) Sophie E. Legge et al. JAMA Psychiatry
- A functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypes
- (2019) Judit Lazary et al. JOURNAL OF AFFECTIVE DISORDERS
- Phenolic compounds from nutmeg ( Myristica fragrans Houtt.) inhibit the endocannabinoid‐modulating enzyme fatty acid amide hydrolase
- (2019) Abir T. El‐Alfy et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression
- (2019) Xiangjuan Kong et al. MEDICINE
- Schizophrenia
- (2019) Stephen R. Marder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour
- (2019) Elizabeth A. Hay et al. PSYCHONEUROENDOCRINOLOGY
- Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
- (2019) Eun-Sang Hwang et al. BEHAVIOURAL BRAIN RESEARCH
- Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats
- (2019) Bin Dong et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD
- (2019) Neta Maymon et al. NEUROPHARMACOLOGY
- The endocannabinoid system in mental disorders: Evidence from human brain studies
- (2018) Inés Ibarra-Lecue et al. BIOCHEMICAL PHARMACOLOGY
- The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System
- (2018) Anthony L. Berger et al. BIOLOGICAL PSYCHIATRY
- Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
- (2018) Sharon Fidelman et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects
- (2018) Aitziber Mendiguren et al. LIFE SCIENCES
- Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats
- (2018) Guoxiang Fang et al. NEUROCHEMICAL RESEARCH
- Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats
- (2018) Giorgia Boero et al. NEUROPHARMACOLOGY
- Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity
- (2018) Amir Segev et al. NEUROPSYCHOPHARMACOLOGY
- Sex differences in psychiatric disorders: what we can learn from sex chromosome aneuploidies
- (2018) Tamar Green et al. NEUROPSYCHOPHARMACOLOGY
- Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2
- (2018) Sabrina Francesca Lisboa et al. NEUROPSYCHOPHARMACOLOGY
- Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
- (2018) María S. García-Gutiérrez et al. Neurotherapeutics
- Familial abnormalities of endocannabinoid signaling in schizophrenia
- (2018) Dagmar Koethe et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
- (2018) Gaurav Bedse et al. Translational Psychiatry
- Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats
- (2018) Jonathan J. Simone et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety
- (2018) Andalib Danandeh et al. PSYCHOPHARMACOLOGY
- Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia
- (2018) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
- (2018) Guy Griebel et al. Scientific Reports
- Impact of FAAH genetic variation on fronto-amygdala function during emotional processing
- (2018) Anne Gärtner et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety
- (2018) Maria Morena et al. JOURNAL OF NEUROSCIENCE
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
- (2018) Tina Zimmermann et al. NEUROPSYCHOPHARMACOLOGY
- Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat
- (2018) Stephanie M. Perez et al. SCHIZOPHRENIA RESEARCH
- Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
- (2017) Laura Kranaster et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event
- (2017) Nurit Aisenberg et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative analysis of MBD-seq and MeDIP-seq and estimation of gene expression changes in a rodent model of schizophrenia
- (2017) Jennifer L. Neary et al. GENOMICS
- Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
- (2017) Salvina Maria de Campos-Carli et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents
- (2017) Tingting Duan et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex
- (2017) Ana F Almeida-Santos et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event
- (2017) Noa Shoshan et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The CB1 Receptor as the Cornerstone of Exostasis
- (2017) Pier Vincenzo Piazza et al. NEURON
- Chronic stress leads to epigenetic dysregulation in the neuropeptide-Y and cannabinoid CB1 receptor genes in the mouse cingulate cortex
- (2017) Ermelinda Lomazzo et al. NEUROPHARMACOLOGY
- CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
- (2017) Arnau Busquets-Garcia et al. NEUROPSYCHOPHARMACOLOGY
- Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
- (2017) Ziva D Cooper et al. NEUROPSYCHOPHARMACOLOGY
- Anxious behavior induces elevated hippocampal Cb 2 receptor gene expression
- (2017) James M. Robertson et al. NEUROSCIENCE
- Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders
- (2017) Nachshon Korem et al. NEUROSCIENCE
- Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus
- (2017) Yong Li et al. NEUROSCIENCE
- The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
- (2017) Marta Kruk-Slomka et al. NEUROTOXICITY RESEARCH
- Changes in the cannabinoids receptors in rats following treatment with antidepressants
- (2017) Irena Smaga et al. NEUROTOXICOLOGY
- A behavioral and pharmacological characterization of palatable diet alternation in mice
- (2017) Catherine F. Moore et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
- (2017) Andrea Chicca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia
- (2017) David J. Clarke et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
- (2017) Sagnik Bhattacharyya et al. Scientific Reports
- Selectively Impaired Endocannabinoid-Dependent Long-Term Depression in the Lateral Habenula in an Animal Model of Depression
- (2017) Hoyong Park et al. Cell Reports
- Schizophrenia and depression, two poles of endocannabinoid system deregulation
- (2017) María Rodríguez-Muñoz et al. Translational Psychiatry
- Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
- (2017) Qing-Rong Liu et al. Scientific Reports
- Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice
- (2016) Mallory E. Bowers et al. BEHAVIOURAL BRAIN RESEARCH
- Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
- (2016) Mohini Ranganathan et al. BIOLOGICAL PSYCHIATRY
- Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions
- (2016) Catherine H. Demers et al. BIOLOGICAL PSYCHIATRY
- Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
- (2016) Yoan Mihov BIOLOGICAL PSYCHIATRY
- Human Laboratory Studies on Cannabinoids and Psychosis
- (2016) Mohamed Sherif et al. BIOLOGICAL PSYCHIATRY
- Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels
- (2016) Imke Jenniches et al. BIOLOGICAL PSYCHIATRY
- Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
- (2016) Shanshan Wang et al. BRAIN RESEARCH BULLETIN
- Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1receptor inverse agonist AM-251 after physical stress in mice
- (2016) Sattar Ostadhadi et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
- (2016) P.H. Gobira et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
- (2016) Judit Lazary et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Targeting the Endocannabinoid System in Psychiatric Illness
- (2016) Martin A. Katzman et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Anatomical characterization of the cannabinoid CB1receptor in cell-type-specific mutant mouse rescue models
- (2016) Ana Gutiérrez-Rodríguez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats
- (2016) Dhanush Haspula et al. JOURNAL OF NEUROCHEMISTRY
- Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala
- (2016) S. Di et al. JOURNAL OF NEUROSCIENCE
- Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
- (2016) Miquel Bioque et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Schizophrenia
- (2016) Michael J Owen et al. LANCET
- Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
- (2016) Maria Morena et al. NEUROPHARMACOLOGY
- Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia
- (2016) Edina Szűcs et al. NEUROSCIENCE LETTERS
- The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801
- (2016) Marta Kruk-Slomka et al. NEUROTOXICITY RESEARCH
- The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings
- (2016) Andrea Berardi et al. PHARMACOLOGICAL RESEARCH
- Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor
- (2016) Tamaki Hayase PLoS One
- Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species
- (2016) Dylan G. Gee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
- (2016) Kayla A. Chase et al. PSYCHIATRY RESEARCH
- Endocannabinoid concentrations in hair are associated with PTSD symptom severity
- (2016) Sarah Wilker et al. PSYCHONEUROENDOCRINOLOGY
- Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
- (2016) J. Megan Gray et al. PSYCHONEUROENDOCRINOLOGY
- Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
- (2016) Clémentine Bosch-Bouju et al. Cell Reports
- The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors
- (2015) Priscila A. Batista et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
- (2015) Marta Kruk-Slomka et al. BEHAVIOURAL BRAIN RESEARCH
- Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression
- (2015) Ricardo Lage et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
- (2015) Stephan Guggenhuber et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
- (2015) Elizabeth Scarr et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The rs1049353 Polymorphism in the CNR1 Gene Interacts With Childhood Abuse to Predict Posttraumatic Threat Symptoms
- (2015) Natalie Mota et al. JOURNAL OF CLINICAL PSYCHIATRY
- Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior
- (2015) Roberta Imperatore et al. JOURNAL OF NEUROCHEMISTRY
- Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
- (2015) J. M. Gray et al. JOURNAL OF NEUROSCIENCE
- Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses
- (2015) Luara A Batista et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- Endocannabinoid signalling and the deteriorating brain
- (2015) Vincenzo Di Marzo et al. NATURE REVIEWS NEUROSCIENCE
- Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia
- (2015) Stephanie M Perez et al. NEUROPSYCHOPHARMACOLOGY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
- (2015) Eva M. Marco et al. PLoS One
- Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
- (2015) Sabrina F. Lisboa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms
- (2015) Paula Suárez-Pinilla et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
- (2015) Rakesh Jetly et al. PSYCHONEUROENDOCRINOLOGY
- FAAH genetic variation enhances fronto-amygdala function in mouse and human
- (2015) Iva Dincheva et al. Nature Communications
- Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability
- (2015) Martin Häring et al. Frontiers in Behavioral Neuroscience
- Psychiatric Disorders: Diagnosis to Therapy
- (2014) John H. Krystal et al. CELL
- Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
- (2014) Pablo Roitman et al. CLINICAL DRUG INVESTIGATION
- Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity
- (2014) Zhen Zhang et al. HIPPOCAMPUS
- Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications
- (2014) Colin Cameron et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents
- (2014) Arlette F. Buchmann et al. JOURNAL OF NEURAL TRANSMISSION
- Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
- (2014) Aurelijus Burokas et al. JOURNAL OF NEUROCHEMISTRY
- Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system
- (2014) Hua-ning Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Endocannabinoids, Related Compounds and Their Metabolic Routes
- (2014) Filomena Fezza et al. MOLECULES
- Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
- (2014) Nachshon Korem et al. NEUROPSYCHOPHARMACOLOGY
- Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention
- (2014) Mallory E Bowers et al. NEUROPSYCHOPHARMACOLOGY
- Dissociable Deficits of Executive Function Caused by Gestational Adversity are Linked to Specific Transcriptional Changes in the Prefrontal Cortex
- (2014) Nicola M Grissom et al. NEUROPSYCHOPHARMACOLOGY
- Peripheral and intra-dorsolateral striatum injections of the cannabinoid receptor agonist WIN 55,212-2 impair consolidation of stimulus–response memory
- (2014) J. Goodman et al. NEUROSCIENCE
- Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
- (2014) Irena Smaga et al. NEUROTOXICITY RESEARCH
- The microinjection of a cannabinoid agonist into the accumbens shell induces anxiogenesis in the elevated plus-maze
- (2014) Larissa Kochenborger et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice
- (2014) Amine Bahi et al. PHYSIOLOGY & BEHAVIOR
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population
- (2014) Joon Seol Bae et al. PSYCHIATRIC GENETICS
- CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice
- (2014) Ramy Khella et al. PSYCHOPHARMACOLOGY
- Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats
- (2014) Thércia G. Viana et al. PSYCHOPHARMACOLOGY
- Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia
- (2014) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia
- (2014) Rodrigo Ferretjans et al. SCHIZOPHRENIA RESEARCH
- Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation
- (2014) Brian C. Shonesy et al. Cell Reports
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
- (2014) R J Bluett et al. Translational Psychiatry
- Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray
- (2013) A.F. Almeida-Santos et al. BEHAVIOURAL BRAIN RESEARCH
- CB1receptor signaling regulates social anxiety and memory
- (2013) Y. Litvin et al. GENES BRAIN AND BEHAVIOR
- Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice
- (2013) Mano Aliczki et al. HORMONES AND BEHAVIOR
- Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
- (2013) Mateus M. Bergamaschi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
- (2013) Weiping Yu et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population
- (2013) Dongxiao Tong et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats
- (2013) Christian G Reich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans
- (2013) Christine A. Rabinak et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
- (2013) Jenny Ceccarini et al. NEUROIMAGE
- Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression
- (2013) Amir Segev et al. NEUROPSYCHOPHARMACOLOGY
- Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
- (2013) Miquel Bioque et al. NEUROPSYCHOPHARMACOLOGY
- No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample
- (2013) Claudia Pisanu et al. PSYCHIATRY RESEARCH
- Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
- (2013) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
- (2013) Eti Ganon-Elazar et al. PSYCHONEUROENDOCRINOLOGY
- Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus
- (2013) Rodrigo Rorato et al. REGULATORY PEPTIDES
- Endocannabinoid metabolism in the prefrontal cortex in schizophrenia
- (2013) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
- (2013) Carolina Muguruza et al. SCHIZOPHRENIA RESEARCH
- Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models
- (2013) Tim Karl Frontiers in Behavioral Neuroscience
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
- (2012) Arpana Agrawal et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test
- (2012) Priscila Cagni et al. BEHAVIOURAL BRAIN RESEARCH
- The Endocannabinoid System and Pain
- (2012) Josee Guindon et al. CNS & Neurological Disorders-Drug Targets
- Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia
- (2012) Marta Costa et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
- (2012) Kwang Choi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
- (2012) Marina Mitjans et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure
- (2012) M N Hill et al. MOLECULAR PSYCHIATRY
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
- Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation
- (2012) J. Kleijn et al. NEUROCHEMISTRY INTERNATIONAL
- The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior
- (2012) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Cannabinoid facilitation of fear extinction memory recall in humans
- (2012) Christine A. Rabinak et al. NEUROPHARMACOLOGY
- Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
- (2012) Alejandro Aparisi Rey et al. NEUROPSYCHOPHARMACOLOGY
- Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms
- (2012) Alline Cristina Campos et al. NEUROSCIENCE LETTERS
- Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
- (2012) Maha M. ElBatsh et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats
- (2012) K. Yaragudri Vinod et al. PLoS One
- The CNR1 gene in depression and schizophrenia — Is there an association with early improvement and response?
- (2012) Rebecca Schennach et al. PSYCHIATRY RESEARCH
- Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
- (2012) Marc Schroeder et al. PSYCHONEUROENDOCRINOLOGY
- Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia
- (2012) Kimberly J. Jenko et al. SCHIZOPHRENIA RESEARCH
- Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
- (2012) Joëlle Desfossés et al. Frontiers in Psychiatry
- Endocannabinoid system dysfunction in mood and related disorders
- (2011) C. H. Ashton et al. ACTA PSYCHIATRICA SCANDINAVICA
- Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice
- (2011) Sudhir N. Umathe et al. BEHAVIOURAL BRAIN RESEARCH
- Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
- (2011) Nathalie Gérard et al. BIOLOGICAL PSYCHIATRY
- Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses
- (2011) Arnau Busquets-Garcia et al. BIOLOGICAL PSYCHIATRY
- Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor
- (2011) D. Minocci et al. JOURNAL OF AFFECTIVE DISORDERS
- The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
- (2011) Francisco Javier Bermudez-Silva et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense Stress
- (2011) Eti Ganon-Elazar et al. NEUROPSYCHOPHARMACOLOGY
- CB1 receptor-deficient mice as a model for depression
- (2011) O. Valverde et al. NEUROSCIENCE
- Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
- (2011) Guoqiang Xing et al. NEUROSCIENCE LETTERS
- Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review
- (2011) R. J. Van Lieshout et al. Obesity Reviews
- Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
- (2011) Natale R. Sciolino et al. PHARMACOLOGICAL RESEARCH
- Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression
- (2011) E. Heyman et al. PSYCHONEUROENDOCRINOLOGY
- Energy balance regulation by endocannabinoids at central and peripheral levels
- (2011) Carmelo Quarta et al. TRENDS IN MOLECULAR MEDICINE
- Supply and demand for endocannabinoids
- (2011) Bradley E. Alger et al. TRENDS IN NEUROSCIENCES
- Sexually Dimorphic Effects of Cannabinoid Compounds on Emotion and Cognition
- (2011) Tiziana Rubino et al. Frontiers in Behavioral Neuroscience
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
- (2011) Eva Marco Frontiers in Behavioral Neuroscience
- Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors
- (2010) MS García-Gutiérrez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype
- (2010) Ester Aso et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system and psychiatric disorders
- (2010) Daniela Parolaro et al. EXPERIMENTAL NEUROLOGY
- Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine
- (2010) Cinzia Guidali et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
- (2010) Y. Gao et al. JOURNAL OF NEUROSCIENCE
- Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice
- (2010) Leyre Urigüen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
- (2010) Mohammad Reza Zarrindast et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
- (2010) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition
- (2010) S. Rossi et al. MOLECULAR PHARMACOLOGY
- Depression-like phenotype following chronic CB1 receptor antagonism
- (2010) Chad E. Beyer et al. NEUROBIOLOGY OF DISEASE
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission
- (2010) Asami Tanimura et al. NEURON
- Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats
- (2010) N. Realini et al. NEUROPHARMACOLOGY
- Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress
- (2010) Wei Wang et al. NEUROPSYCHOPHARMACOLOGY
- Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience
- (2010) A.C. Campos et al. NEUROSCIENCE
- Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
- (2010) Palmiero Monteleone et al. PHARMACOLOGICAL RESEARCH
- A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy
- (2010) Sarah A. Eisenstein et al. PHARMACOLOGICAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
- (2010) Steven G. Kinsey et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents
- (2010) Mark D. Black et al. PSYCHOPHARMACOLOGY
- Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype
- (2009) Judit Lazary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
- (2009) Emmanuel S. Onaivi et al. Annals of the New York Academy of Sciences
- Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
- (2009) Gunnar Thiemann et al. BEHAVIOURAL BRAIN RESEARCH
- Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats
- (2009) Christian G. Reich et al. BEHAVIOURAL BRAIN RESEARCH
- Prepulse inhibition and genetic mouse models of schizophrenia
- (2009) Susan B. Powell et al. BEHAVIOURAL BRAIN RESEARCH
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
- (2009) Gernot Riedel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Involvement of hypothalamic peptides in the anorectic action of the CB1receptor antagonist rimonabant (SR 141716)
- (2009) Aaron N. A. Verty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
- (2009) Guy A. Cabral et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cannabinoids modulate hippocampal memory and plasticity
- (2009) Hila Abush et al. HIPPOCAMPUS
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Altered CB1receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
- (2009) Antonio Rodríguez-Gaztelumendi et al. JOURNAL OF NEUROCHEMISTRY
- The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
- (2009) María S García-Gutiérrez et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833
- (2009) Bing Hu et al. PAIN
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- (2009) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats
- (2009) J. Haller et al. PSYCHOPHARMACOLOGY
- Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder
- (2008) Ake T. Lu et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system
- (2008) Mohammad-Reza Zarrindast et al. BEHAVIOURAL PHARMACOLOGY
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to Schizophrenia
- (2008) Mihály Hajós et al. BIOLOGICAL PSYCHIATRY
- Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
- (2008) Ahmad R. Hariri et al. BIOLOGICAL PSYCHIATRY
- Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test
- (2008) Sabrina F. Lisboa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia
- (2008) Daniela Vigano et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents
- (2008) Matthew N. Hill et al. JOURNAL OF NEURAL TRANSMISSION
- BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1knockout mice
- (2008) Ester Aso et al. JOURNAL OF NEUROCHEMISTRY
- Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
- (2008) Matthew N. Hill et al. JOURNAL OF NEUROCHEMISTRY
- Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
- (2008) Stéphane Potvin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
- (2008) Vincenzo Micale et al. NEUROPSYCHOPHARMACOLOGY
- Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
- (2008) M. Hill et al. PHARMACOPSYCHIATRY
- Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
- (2008) Emmanuel S. Onaivi et al. PLoS One
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
- (2007) Nora Hamdani et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
- (2007) T. Rubino et al. NEUROPHARMACOLOGY
- The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
- (2007) Maria Scherma et al. NEUROPHARMACOLOGY
- Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
- (2007) Fabricio A. Moreira et al. NEUROPHARMACOLOGY
- Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice
- (2007) Nima Naderi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started